One patient had no discomfort associated with a rare aneurysm on her jugular vein — until a rupture required immediate surgery.
Jane Racey Gleeson
Jane Racey Gleeson has been a member of the University of Michigan Frankel Cardiovascular Center’s communications team as a contributing writer for the past three years. She works with the team to produce targeted communications that meet the Frankel CVC’s goals. Gleeson’s 30 years in the technical communications field extend to custom publications, website development and integrated marketing for a variety of clients. She received her bachelor’s degree with honors in journalism from Oakland University in Rochester, Michigan.
Could a tiny device designed to avert stroke-provoking clots be a substitute for medication? The technology is an option for certain at-risk patients.
For those with a rare form of blood clots called CTEPH, a complex surgery is often the fix when medication fails. A U-M cardiac surgeon speaks about the procedure.